Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
02 Ene 2026
GEMICOMED: Club Bibliográfico | 27/06/2025
Dra. Sabina Herrera Fernández. Servicio de Enfermedades Infecciosas. Hospital Clinic de Barcelona